{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:18Z","timestamp":1793141838468,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver surveillance imaging is essential for detecting early asymptomatic metastases in uveal melanoma, which predominantly involves the liver. Early detection may improve treatment opportunities, but variability in imaging protocols and a lack of consensus on surveillance duration present challenges. This study aimed to evaluate our systemic surveillance protocol, optimise pathways, and assess risk factors for metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed patients diagnosed with uveal melanoma between 2006 and 2021 who underwent hepatic imaging surveillance at Sheffield Teaching Hospitals NHS Foundation Trust. Demographics, tumour characteristics, treatments, disease status, and survival outcomes were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1086 patients (45% female, 79% White; median age 68 years), 315 (29%) developed metastases, with 293 (93%) detected within five years of ocular treatment. The number needed to scan (NNS) increased substantially after five years, indicating reduced detection efficiency. Higher T stage and ciliary body involvement were significantly associated with increased metastatic risk (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most metastases from uveal melanoma occur within five years of treatment. Personalised, risk-based surveillance strategies considering tumour stage and location may improve efficiency and optimise healthcare resource use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03445-7","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:15:52Z","timestamp":1776327352000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatic metastasis surveillance in uveal melanoma: a retrospective cohort study from a UK tertiary centre (2006\u20132022)"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-0359","authenticated-orcid":false,"given":"Benjamin","family":"Rea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahan","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Maiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Ochieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lanham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharabh","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Hawthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarit","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umiya","family":"Harley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-3168","authenticated-orcid":false,"given":"Hibba","family":"Quhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-4987","authenticated-orcid":false,"given":"Sachin","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"3445_CR1","unstructured":"Eye cancer (ocular melanoma) https:\/\/www.macmillan.org.uk\/cancer-information-and-support\/melanoma\/eye-cancer cited 7 Apr 2024]."},{"key":"3445_CR2","first-page":"1230","volume":"6","author":"P Jovanovic","year":"2013","unstructured":"Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, Vlajkovic S, Cekic S, Stefanovic V. Ocular melanoma: an overview of the current status. Int J Clin Exp Pathol. 2013;6:1230\u201344.","journal-title":"Int J Clin Exp Pathol"},{"key":"3445_CR3","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","volume":"123","author":"M Diener-West","year":"2005","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123:1639\u201343.","journal-title":"Arch Ophthalmol"},{"key":"3445_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000495113","volume":"5","author":"LT Xu","year":"2019","unstructured":"Xu LT, Funchain PF, Bena JF, Li M, Tarhini A, Berber E, et al. Uveal melanoma metastatic to the liver: Treatment trends and outcomes. Ocul Oncol Pathol. 2019;5:323\u201332.","journal-title":"Ocul Oncol Pathol"},{"key":"3445_CR5","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","volume":"22","author":"M Diener-West","year":"2004","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22:2438\u201344.","journal-title":"J Clin Oncol"},{"key":"3445_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1179\/joc.2011.23.5.300","volume":"23","author":"A Farolfi","year":"2011","unstructured":"Farolfi A, Ridolfi L, Guidoboni M, Milandri C, Calzolari F, Scarpi E, et al. Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study. J Chemother. 2011;23:300\u20135.","journal-title":"J Chemother"},{"key":"3445_CR7","doi-asserted-by":"crossref","unstructured":"Nebhan CA, Johnson DB, Deppen SA, Daniels AB. Surveillance for Metastatic Disease. Uveal Melanoma. Cham: Springer International Publishing; 2021. pp. 153\u201371.","DOI":"10.1007\/978-3-030-78117-0_12"},{"key":"3445_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamaophthalmol.2015.4810","volume":"134","author":"MM Choudhary","year":"2016","unstructured":"Choudhary MM, Gupta A, Bena J, Emch T, Singh AD. Hepatic ultrasonography for surveillance in patients with uveal melanoma. JAMA Ophthalmol. 2016;134:174\u201380.","journal-title":"JAMA Ophthalmol"},{"key":"3445_CR9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/cancers16091712","volume":"16","author":"SA Mirshahvalad","year":"2024","unstructured":"Mirshahvalad SA, Zamani-Siahkali N, Pirich C, Beheshti M. A systematic review and meta-analysis on the diagnostic and prognostic values of 18F-FDG PET in uveal melanoma and its hepatic metastasis. Cancers (Basel). 2024;16:1712.","journal-title":"Cancers (Basel)"},{"key":"3445_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5301\/ejo.5000049","volume":"22","author":"A Freton","year":"2012","unstructured":"Freton A, Chin KJ, Raut R, Tena LB, Kivel\u00e4 T, Finger PT. Initial PET\/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients. Eur J Ophthalmol. 2012;22:236\u201343.","journal-title":"Eur J Ophthalmol"},{"key":"3445_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/bjo.2005.069823","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC. Whole body PET\/CT for initial staging of choroidal melanoma. Br J Ophthalmol. 2005;89:1270\u20134.","journal-title":"Br J Ophthalmol"},{"key":"3445_CR12","first-page":"409","volume":"57","author":"K Sek","year":"2016","unstructured":"Sek K, Wilson D, Paton K, Benard F. The role of 18F-FDG PET\/CT in assessment of uveal melanoma and likelihood of primary tumour visualisation based on AJCC tumour size. J Nucl Med. 2016;57:409.","journal-title":"J Nucl Med"},{"key":"3445_CR13","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ejca.2015.07.013","volume":"51","author":"P Nathan","year":"2015","unstructured":"Nathan P, Cohen V, Coupland S, Curtis K, Damato B, Evans J, et al. Uveal melanoma UK national guidelines. Eur J Cancer. 2015;51:2404\u201312.","journal-title":"Eur J Cancer"},{"key":"3445_CR14","unstructured":"ESMO. ESMO Clinical Practice Guidelines: Melanoma and Skin Cancers. [cited 3 Nov 2024]. Available: https:\/\/www.esmo.org\/guidelines\/guidelines-by-topic\/melanoma-and-skin-cancers."},{"key":"3445_CR15","first-page":"120","volume":"18","author":"PK Rao","year":"2020","unstructured":"Rao PK, Barker C, Coit DG, Joseph RW, Materin M, Rengan R, et al. NCCN Guidelines Insights: Uveal Melanoma, version 1. 2019. J Natl Compr Canc Netw. 2020;18:120\u201331.","journal-title":"2019. J Natl Compr Canc Netw"},{"key":"3445_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41433-022-02198-w","volume":"37","author":"V Chadha","year":"2023","unstructured":"Chadha V, Cauchi P, Kincaid W, Waterston A, Schipani S, Salvi S, et al. Consensus statement for metastatic surveillance of uveal melanoma in Scotland. Eye. 2023;37:894\u20139.","journal-title":"Eye"},{"key":"3445_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41416-021-01274-4","volume":"124","author":"H Wang","year":"2021","unstructured":"Wang H, Elsheikh M, Gilmour K, Cohen V, Sagoo MS, Damato B, et al. Impact of COVID-19 pandemic on eye cancer care in United Kingdom. Br J Cancer. 2021;124:1357\u201360.","journal-title":"Br J Cancer"},{"key":"3445_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/bjophthalmol-2020-317949","volume":"106","author":"G Garg","year":"2022","unstructured":"Garg G, Finger PT, Kivel\u00e4 TT, Simpson ER, Gallie BL, Saakyan S, et al. Patients presenting with metastases: stage IV uveal melanoma, an international study. Br J Ophthalmol. 2022;106:510\u20137.","journal-title":"Br J Ophthalmol"},{"key":"3445_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.5858\/133.8.1197","volume":"133","author":"PT Finger","year":"2009","unstructured":"Finger PT. The 7th edition AJCC staging system for eye cancer: An international language for ophthalmic oncology. Arch Pathol Lab Med. 2009;133:1197\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"3445_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","volume":"127","author":"CL Shields","year":"2009","unstructured":"Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989\u201398.","journal-title":"Arch Ophthalmol"},{"key":"3445_CR21","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.jcjo.2024.07.014","volume":"60","author":"A Hagstr\u00f6m","year":"2025","unstructured":"Hagstr\u00f6m A, Witzenhausen H, St\u00e5lhammar G. Tailoring surveillance imaging in uveal melanoma based on individual metastatic risk. Can J Ophthalmol. 2025;60:e240\u201352.","journal-title":"Can J Ophthalmol"},{"key":"3445_CR22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.3390\/cancers14092187","volume":"14","author":"AC Rola","year":"2022","unstructured":"Rola AC, Kalirai H, Taktak AFG, Eleuteri A, Krishna Y, Hussain R, et al. A retrospective analysis of 10 years of liver surveillance undertaken in uveal melanoma patients treated at the supraregional \u201cLiverpool ocular oncology centre\u201d, UK. Cancers (Basel). 2022;14:2187.","journal-title":"Cancers (Basel)"},{"key":"3445_CR23","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","volume":"23","author":"P Rietschel","year":"2005","unstructured":"Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol. 2005;23:8076\u201380.","journal-title":"J Clin Oncol"},{"key":"3445_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1245\/ASO.2005.06.032","volume":"12","author":"M Rivoire","year":"2005","unstructured":"Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, N\u00e9grier S, Grange J-D. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol. 2005;12:422\u20138.","journal-title":"Ann Surg Oncol"},{"key":"3445_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2214\/ajr.157.6.1950883","volume":"157","author":"JG Lorigan","year":"1991","unstructured":"Lorigan JG, Wallace S, Mavligit GM. The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. AJR Am J Roentgenol. 1991;157:1279\u201381.","journal-title":"AJR Am J Roentgenol"},{"key":"3445_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaophthalmol.2018.2466","volume":"136","author":"AM Lane","year":"2018","unstructured":"Lane AM, Kim IK, Gragoudas ES. Survival rates in patients after treatment for metastasis from uveal melanoma. JAMA Ophthalmol. 2018;136:981\u20136.","journal-title":"JAMA Ophthalmol"},{"key":"3445_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/eye.2016.275","volume":"31","author":"S Kaliki","year":"2017","unstructured":"Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye. 2017;31:241\u201357.","journal-title":"Eye"},{"key":"3445_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.4103\/IJO.IJO_2453_24","volume":"73","author":"R Bansal","year":"2025","unstructured":"Bansal R, Sener H, Shields JA, Shields CL. Long-term non-conditional and conditional metastasis of uveal melanoma by tumor size category in 8034 patients. Indian J Ophthalmol. 2025;73:893\u20139.","journal-title":"Indian J Ophthalmol"},{"key":"3445_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.64.1.15","volume":"64","author":"A-N Chao","year":"2023","unstructured":"Chao A-N, Rose K, Racher H, Altomare F, Krema H. Cytogenetic abnormalities for predicting the risk of metastases in choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 2023;64:15.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3445_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/bjophthalmol-2012-302323","volume":"97","author":"E Marshall","year":"2013","unstructured":"Marshall E, Romaniuk C, Ghaneh P, Wong H, McKay M, Chopra M, et al. MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol. 2013;97:159\u201363.","journal-title":"Br J Ophthalmol"},{"key":"3445_CR31","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114:2309\u201315.","journal-title":"Ophthalmology"},{"key":"3445_CR32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881\u20135.","journal-title":"Ophthalmology"},{"key":"3445_CR33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/eye.2015.51","volume":"29","author":"CL Shields","year":"2015","unstructured":"Shields CL, Kaliki S, Cohen MN, Shields PW, Furuta M, Shields JA. Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture. Eye. 2015;29:1027\u201335.","journal-title":"Eye"},{"key":"3445_CR34","doi-asserted-by":"publisher","unstructured":"Semeniuk O, Yu E, Rivard MJ. Current and Emerging Radiotherapy Options for Uveal Melanoma. Cancers. 2024;16. https:\/\/doi.org\/10.3390\/cancers16051074.","DOI":"10.3390\/cancers16051074"},{"key":"3445_CR35","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3445_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/archopht.1996.01100130743022","volume":"114","author":"SE Coupland","year":"1996","unstructured":"Coupland SE, Sidiki S, Clark BJ, McClaren K, Kyle P, Lee WR. Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation. Arch Ophthalmol. 1996;114:751\u20136.","journal-title":"Arch Ophthalmol"},{"key":"3445_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-336","volume":"14","author":"VL Tsikitis","year":"2014","unstructured":"Tsikitis VL, Larson DW, Huebner M, Lohse CM, Thompson PA. Predictors of recurrence free survival for patients with stage II and III colon cancer. BMC Cancer. 2014;14:336.","journal-title":"BMC Cancer"},{"key":"3445_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ophtha.2021.11.018","volume":"129","author":"MC Gelmi","year":"2022","unstructured":"Gelmi MC, Bas Z, Malkani K, Ganguly A, Shields CL, Jager MJ. Adding the Cancer Genome Atlas chromosome classes to American Joint Committee on Cancer system offers more precise prognostication in uveal melanoma. Ophthalmology. 2022;129:431\u20137.","journal-title":"Ophthalmology"},{"key":"3445_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.61.3.31","volume":"61","author":"M Dogrus\u00f6z","year":"2020","unstructured":"Dogrus\u00f6z M, Brouwer NJ, de Geus SJR, Ly LV, B\u00f6hringer S, van Duinen SG, et al. Prognostic factors five years after enucleation for uveal melanoma. Invest Ophthalmol Vis Sci. 2020;61:31.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3445_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bjo.62.6.420","volume":"62","author":"LE Zimmerman","year":"1978","unstructured":"Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol. 1978;62:420\u20135.","journal-title":"Br J Ophthalmol"},{"key":"3445_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1167\/iovs.64.13.44","volume":"64","author":"JZ Lim","year":"2023","unstructured":"Lim JZ, Crawford AZ, McGhee CNJ. Tumor profiles of late presentation uveal ring melanoma with novel characteristics - A case series. Invest Ophthalmol Vis Sci. 2023;64:44.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03445-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:41:49Z","timestamp":1781541709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03445-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,5]]}},"alternative-id":["3445"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03445-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}